Ortho Biotech News
Most Popular Ortho Biotech Story
J&J unit's prostate cancer drug improves survival
A independent data monitoring committee has recommended that advanced prostate cancer patients in the placebo arm of a Phase III trial evaluating Ortho Biotech Oncology R&D's abiraterone acetate Read more...
Latest Headlines
- September 10, 2010
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
